Projects
Effectiveness of an eHealth self-management support program for persistent pain after breast cancer treatment KU Leuven
The scientific goals of the project are:
- The primary scientific objective of the study is to determine the effectiveness of an eHealth selfmanagement support program for persistent pain after breast cancer treatment compared to:
1) usual care (i.e. superiority of the eHealth self-management support program) and
2) a comprehensive pain rehabilitation program delivered face-to-face in a physical therapy setting (i.e. ...
Assessment of Mechanical Dyssynchrony as Selection Criterion for CRT Treatment KU Leuven
Cardiac resynchronization therapy is an accepted treatment for patients with heart failure and conduction delays, where the contraction of the left ventricular chamber is re-synchronized by means of a dedicated pacemaker device with several electrodes. Current guideline criteria for selecting patients, however, result in a non-responder rate of approximately 35%. Some studies suggest that such non-responders are even at higher risk because of ...
Hurdle technology based on high pressure treatment and natural antimicrobials. KU Leuven
High pressure (HP) treatment is a novel technology that is gaining a foothold in the commercial non-thermal preservation of high quality chilled foods. It is applied mainly as a post-packaging treatment to eliminate microbial contaminants in heat-sensitive foods, thereby improving their safety and considerably extending shelf-life. The gain in safety and shelf-life that can be achieved in some products, often with little or no loss of ...
68Gallium- and 177Lutetium/NOTA-somatropin for imaging and treatment of GH-R expressing melanoma Ghent University
Cutaneous melanoma is considered to be one of the most deadliest cancers worldwide, with metastasis to other organs being difficult to treat. As the human growth hormone-receptor (GHR) was found to be over-expressed in i.a. different melanoma cell lines, the human growth hormone (recombinant prepared: somatropin) can now be used to visualize and treat these types of cancer in human. Therefore, somatropin will be labeled with a radioactive ...
68Gallium- and 177Lutetium/NOTA-somatropin for imaging and treatment of GH-R expressing melanoma KU Leuven
Cutaneous melanoma is considered to be one of the most deadliest cancers worldwide, with metastasis to other organs being difficult to treat. As the human growth hormone-receptor (GHR) was found to be over-expressed in i.a. different melanoma cell lines, the human growth hormone (recombinant prepared: somatropin) can now be used to visualize and treat these types of cancer in human. Therefore, somatropin will be labeled with a radioactive ...